Skip to the answer

Diclofenac Topical (arthritis pain) Uses, Dosage, Side Effects and Interactions

Brand names
Pennsaid

Pennsaid came 21 years after Voltaren (November 2009) as a topical solution, a form not listed for Voltaren. The FDA now lists it as discontinued.

Voltaren Arthritis Pain

Voltaren Arthritis Pain came 19 years after Voltaren (October 2007) as a topical cream, ointment or gel, a form not listed for Voltaren.

Zorvolex

Zorvolex came 25 years after Voltaren (October 2013) as a capsule, a form not listed for Voltaren. The FDA now lists it as discontinued.

Licart

Licart came 30 years after Voltaren (December 2018) as a skin patch, a form not listed for Voltaren.

Aleve Arthritis Pain

Aleve Arthritis Pain is a brand name for diclofenac topical (arthritis pain).

Lofena

Lofena is a brand name for diclofenac topical (arthritis pain).

Xiclo

Xiclo is a brand name for diclofenac topical (arthritis pain).

Flector

Flector came 18 years after Voltaren (January 2007) as a skin patch, a form not listed for Voltaren.

Voltaren

Voltaren was the first diclofenac topical (arthritis pain) product the FDA approved, in July 1988.

Cataflam

Cataflam came 5 years after Voltaren (November 1993) as a tablet, a form not listed for Voltaren.

Zipsor

Zipsor came 20 years after Voltaren (June 2009) as a capsule, a form not listed for Voltaren.

Cambia

Cambia came 20 years after Voltaren (June 2009) as an oral solution, a form not listed for Voltaren.

Diclofenac topical gel is a non-steroidal anti-inflammatory drug (NSAID) that you rub on the skin to relieve osteoarthritis pain in joints like the knees and hands.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 19, 2026 Where our facts come from

Quick links

Ask Anything About Diclofenac Topical (arthritis pain)Type a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Diclofenac Topical (arthritis pain) in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Diclofenac gel is an NSAID (nonsteroidal anti-inflammatory drug), on the U.S. market since about 1988, that you rub over arthritic knees, hands and similar joints, where it blocks the COX enzyme that makes the prostaglandins behind pain and inflammation. Because far less drug reaches the bloodstream than with tablets, it is a common first choice for osteoarthritis in these joints. Most people tolerate it well, and the usual complaint is redness, itching or dryness where it goes on. It still carries the NSAID boxed warning for heart attack, stroke and serious stomach bleeding, so chest pain, weakness on one side, slurred speech or black stools need emergency care.

Key Takeaways From the HelloPharmacist Team

  • Apply it 4 times a day, measured on the dosing card, using a larger amount for knees, ankles and feet than for hands.
  • Wait an hour before showering, keep clothes off it for 10 minutes, and wash your hands afterward unless your hands were treated.
  • Don't add ibuprofen, naproxen or aspirin on top of it, and tell your pharmacist if you take a blood thinner.
  • Keep heat pads, tight wraps, sun, and other lotions or sunscreen off the treated joint, and never apply it to broken skin.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Diclofenac Topical (arthritis pain).

NSAIDs like diclofenac gel can raise the risk of heart attack, stroke, and serious stomach or intestinal bleeding, which can be fatal.

The heart risk may increase the longer you use it. People who already have heart disease or risk factors for it may be at higher risk. The gel must not be used for pain around coronary artery bypass graft (CABG) surgery.

Stomach and intestinal bleeding, ulcers, and perforation (a hole) can happen at any time, often without warning symptoms. Older adults are at greater risk. Seek emergency help for chest pain, shortness of breath, weakness on one side, slurred speech, black or bloody stools, or vomiting blood.

Read the full warning on DailyMed →

Diclofenac Topical (arthritis pain) by the Numbers

Earliest FDA record
1988
Rank by Medicaid prescriptions
#44 of 1,682 drugs
More prescriptions than 97% of the 1,682 drugs we measure
4.67 million prescriptions, Q1–Q4 2025

Patient Information Guide for Diclofenac Topical (arthritis pain)

What It’s Used For

Diclofenac topical gel is used for joint pain from one condition.

  • Diclofenac sodium topical gel relieves the pain of osteoarthritis in joints suited to topical treatment, such as the knees and hands.
  • It has not been evaluated for joints of the spine, hip, or shoulder.

How It Works

Diclofenac is an NSAID. It blocks the COX enzyme, which lowers the production of prostaglandins, thromboxanes, and prostacyclin. These chemicals are involved in pain and inflammation. It is not fully understood how this leads to pain relief.

Drug Class

Drug Class

  • Nonsteroidal Anti-inflammatory Drug
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Nonsteroidal Anti-inflammatory Drug

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Cyclooxygenase Inhibitors

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)
  • Decreased Prostaglandin Production

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Diclofenac Topical (arthritis pain) in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Other dermatologicals
  • Acetic acid derivatives and related substances
  • Antiinflammatory preparations, non-steroids for topical use

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

The gel is applied to the skin over the affected joint about 4 times a day and gently rubbed in. Use the dosing card in the carton to measure each amount.

Follow the daily limits and instructions from your prescriber and your product label.

  • Knees, ankles, and feet use a larger measured amount than hands, wrists, and elbows.
  • Treat the entire joint. For a foot or hand, that means all of it.
  • Wait at least 1 hour before showering or bathing.
  • Don’t use heat or tight dressings on the treated joint.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Osteoarthritis pain in joints such as the knees and hands

Adults with pain in the knees, ankles or feet Usual dose 4 g of gel to the affected joint 4 times daily Highest dose 16 g a day to any one joint of the lower extremities
  • Apply the gel (4 g) to the affected foot or knee or ankle, 4 times daily, using the dosing card to the 4 g line
Adults with pain in the elbows, wrists or hands Usual dose 2 g of gel to the affected joint 4 times daily Highest dose 8 g a day to any one joint of the upper extremities
  • Apply the gel (2 g) to the affected hand or elbow or wrist, 4 times daily, using the dosing card to the 2 g line

See the Full Dosing Instructions on DailyMed →

Side Effects

The most common side effects happen on the skin where you apply the gel.

Common side effects

  • Skin reactions where the gel is applied
  • Application site dermatitis (red, irritated skin)
  • Itching at the application site
  • Redness at the application site
  • Tingling or prickling of the skin (paresthesia)
  • Dry skin at the application site
  • Dryness
  • Small blisters or bumps (less common)

When to get medical help

  • Chest pain, shortness of breath, weakness on one side of the body, or slurred speech: these can signal a heart attack or stroke. Get emergency help.
  • Black or bloody stools, vomiting blood, or stomach pain: these can signal stomach or intestinal bleeding or ulcers, which can happen without warning.
  • Rash, blistering, peeling skin or other signs of a skin reaction: stop the gel and call your doctor.
  • Swelling of the face or throat, trouble breathing, or wheezing: these can be signs of a severe allergic reaction. Get emergency help.
  • Nausea, unusual tiredness, itching, yellowing of the skin or eyes, dark urine, or pain in the upper right belly: these can signal liver problems. Call your doctor.
  • Swelling or fluid retention, or new or worsening high blood pressure: tell your doctor.
  • Signs of anemia or blood loss, such as unusual paleness or tiredness: tell your doctor.

In studies, about 7% of people using the gel had an application site reaction, compared with about 2% using a gel without the drug. Skin reactions were the most common reason people stopped treatment. Rare but serious reactions, such as severe rash, allergic reactions, bleeding, or liver problems, need prompt medical attention.

Warnings and Precautions

  • Heart attack and stroke: NSAIDs can raise the risk, which may increase with longer use. People with heart disease or risk factors may be at greater risk.
  • Stomach and intestinal bleeding, ulcers, and perforation: These can happen without warning and can be fatal. Risk is higher with a history of ulcers or bleeding, older age, smoking, alcohol, steroids, or blood thinners.
  • Liver effects: Liver test elevations can occur, and severe liver reactions have been reported. Stop and call your doctor if you notice signs of liver trouble.
  • Blood pressure and fluid retention: NSAIDs can cause new or worsening high blood pressure and swelling. Use caution with heart failure.
  • Kidney effects: Long-term NSAID use can injure the kidneys. The gel is not recommended in advanced kidney disease.
  • Serious skin and allergic reactions: These can happen without warning. Stop the gel at the first sign of rash.
  • Anemia: NSAIDs can sometimes cause it, and long-term users with symptoms should have blood counts checked.

Interactions

Tell your pharmacist about all medicines you use, especially these.

  • Aspirin and oral NSAIDs: may increase side effects, including stomach bleeding.
  • Anticoagulants like warfarin: higher risk of serious stomach bleeding.
  • ACE inhibitors: NSAIDs may weaken their blood-pressure-lowering effect.
  • Diuretics (furosemide, thiazides): NSAIDs may reduce their effect and stress the kidneys.
  • Lithium: levels can rise, so watch for toxicity.
  • Methotrexate and cyclosporine: their toxicity may increase.
  • Other skin products: sunscreens, lotions, moisturizers, cosmetics, and other topical medicines on the same skin may change absorption and tolerability.
  • Corticosteroids: the gel can’t replace them. If you take them for a long time, don’t stop them abruptly.

Interactions Listed in the FDA-Approved Label

From the Diclofenac Topical (arthritis pain) prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • What happensDiclofenac's binding to protein is reduced, though clearance of free diclofenac is not altered; the clinical significance is not known, and there is potential for increased adverse effects including increased GI bleeding.
    What to doConcomitant administration is not generally recommended.
  • Anticoagulants For example: warfarin
    What happensThe effects of anticoagulants and NSAIDs on GI bleeding are synergistic, so users of both have a higher risk of serious GI bleeding than users of either drug alone.
  • ACE inhibitors
    What happensNSAIDs may diminish the antihypertensive effect of ACE inhibitors.
    What to doGive this consideration in patients taking NSAIDs with ACE inhibitors.
  • Diuretics (furosemide and thiazides)
    What happensNSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
    What to doObserve the patient closely for signs of renal failure and to assure diuretic efficacy.
  • What happensNSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.
    What to doObserve patients carefully for signs of lithium toxicity.
  • What happensNSAIDs may enhance the toxicity of methotrexate.
    What to doUse caution when given together.
  • What happensConcomitant therapy with diclofenac may increase cyclosporine's nephrotoxicity.
    What to doUse caution when given together.
  • Oral NSAIDs
    What happensSpecific interaction studies were not performed; there is systemic exposure to diclofenac from the gel, up to 6% of the systemic levels of a single oral dose, so concomitant use with oral NSAIDs or aspirin may result in increased adverse NSAID effects.
  • Other topical products (medications, sunscreens, lotions, moisturizers, cosmetics)
    What happensUse on the same skin site has not been tested and may alter local tolerability and absorption.
    What to doShould be avoided.
Read the label’s full interactions text

7 DRUG INTERACTIONS • Concomitant administration of diclofenac and aspirin is not generally recommended because of the potential of increased adverse effects including increased GI bleeding. • Concomitant use of anticoagulants and diclofenac have a risk of serious GI bleeding higher than users of either drug alone. 7.1 Aspirin When diclofenac is administered with aspirin, the binding of diclofenac to protein is reduced, although the clearance of free diclofenac is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of diclofenac and aspirin is not generally recommended because of the potential of increased adverse effects. 7.2 Anticoagulants The effects of anticoagulants such as warfarin and NSAIDs on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone. 7.3 ACE-Inhibitors NSAIDs may diminish the antihypertensive effect of angiotensin converting enzyme (ACE) inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. 7.4 Diuretics Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients. The response has been attributed to inhibition of renal prostaglandin synthesis. During concomitant therapy with NSAIDs, the patient should be observed closely for signs of renal failure, as well as to assure diuretic efficacy. 7.5 Lithium NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance. The mean minimum lithium concentration increased 15% and the renal clearance was decreased by approximately 20%. These effects have been attributed to inhibition of renal prostaglandin synthesis by the NSAID.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Don’t use it if you’re allergic to diclofenac, aspirin, or other NSAIDs, or have had asthma, hives, or allergic-type reactions after taking them.
  • Don’t use it around coronary artery bypass graft (CABG) surgery.
  • Use caution with heart disease, high blood pressure, heart failure, or fluid retention.
  • Use caution with a history of stomach ulcers or bleeding.
  • Tell your doctor about kidney or liver problems.
  • Avoid it in late pregnancy. Its safety in pregnancy has not been established.
  • Breastfeeding: it’s not known whether diclofenac passes into breast milk, so talk with your doctor.
  • Children: safety and effectiveness have not been established.
  • Older adults: they may be more sensitive to NSAIDs and are at greater risk for serious stomach problems. Kidney function may need to be monitored.

Overdose

No overdose or accidental swallowing of the gel has been reported. If a large amount were swallowed, effects like those of diclofenac tablets could occur, such as drowsiness, nausea, vomiting, stomach pain, and possibly bleeding, high blood pressure, or kidney problems. Call Poison Control at 1-800-222-1222 or seek emergency care.

How Your Body Processes It

Only a small amount of diclofenac gets into the bloodstream from the gel. On average, it is about 6% of the exposure from oral diclofenac. With recommended use on one knee, exposure is about 17 times lower than with oral tablets. Using heat on the area after applying the gel was not tested, so combining the gel with heat is not recommended.

Storage

Store at 20°C to 25°C (68°F to 77°F). Store the dosing card with your diclofenac sodium topical gel.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Diclofenac Topical (arthritis pain): Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Diclofenac Topical (arthritis pain) — the kind of thing our pharmacy team would talk through with you at the counter.

What is diclofenac gel used for?

It relieves osteoarthritis pain in joints you can treat on the skin, like your knees and hands. It hasn’t been studied for the spine, hip, or shoulder, so don’t use it there unless your prescriber tells you to.

How do I apply diclofenac gel?

Measure the gel onto the dosing card from the carton, then gently rub it into the whole joint, about 4 times a day. Follow your prescriber’s directions and the daily limits on your label. Wash your hands afterward unless your hands were the treated joint. If they were, wait at least an hour.

Can I shower, use heat, or wear clothes over it after applying?

Wait at least 1 hour before showering or bathing, and avoid gloves or clothing over the area for at least 10 minutes. Don’t use heat or tight dressings on the joint, and keep it out of the sun. Don’t put sunscreen or lotions on the same spot either.

What side effects should I expect?

Mostly skin reactions where you apply it, such as redness, itching, dryness, or irritation. Call your doctor if you get a rash or blistering. Seek emergency help for chest pain, trouble breathing, black stools, or swelling of the face or throat.

Can I take it with aspirin, ibuprofen, or blood thinners?

Be careful. Using it with aspirin or oral NSAIDs may increase side effects, and with blood thinners like warfarin it raises the risk of serious stomach bleeding. Check with me or your prescriber before combining them.

Is it safe during pregnancy?

Its safety in pregnancy hasn’t been established, and it should be avoided in late pregnancy because it may harm the baby’s heart circulation. If you’re pregnant or breastfeeding, talk with your doctor first.

Is diclofenac topical (arthritis pain) available over the counter?

No. Diclofenac topical (arthritis pain) is a prescription medicine: every diclofenac topical (arthritis pain) product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was diclofenac topical (arthritis pain) first available?

The earliest FDA record we hold for diclofenac topical (arthritis pain) is from 1988: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when diclofenac topical (arthritis pain) was first used.

What is the brand name of diclofenac topical (arthritis pain)?

Diclofenac topical (arthritis pain) is the generic name. Its brand names are Pennsaid, Voltaren Arthritis Pain, Zorvolex, Licart, Aleve Arthritis Pain and 7 more.

What is the generic name of Pennsaid?

The generic name of Pennsaid is diclofenac topical (arthritis pain). A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is diclofenac topical (arthritis pain)?

Diclofenac topical (arthritis pain) belongs to the drug class Nonsteroidal Anti-inflammatory Drug, its established pharmacologic class on the FDA label. The FDA also groups it by how it works: Cyclooxygenase Inhibitor.

Is there a diclofenac topical (arthritis pain) shortage?

No. Diclofenac topical (arthritis pain) is not on the FDA's drug shortage list as of Nov 21, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the diclofenac topical (arthritis pain) prescribing information (package insert)?

The full FDA-approved prescribing information for diclofenac topical (arthritis pain), also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Proficient Rx LP's, revised Nov 1, 2019, and links to it on DailyMed.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Diclofenac Topical (arthritis pain)

Skip the scrolling. Ask in your own words and get an answer from Diclofenac Topical (arthritis pain)’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Diclofenac Topical (arthritis pain)’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Diclofenac Topical (arthritis pain) on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Diclofenac Topical (arthritis pain) Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Diclofenac Topical (arthritis pain) on the U.S. Market: Products, Makers and Brands

How Diclofenac Topical (arthritis pain) appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

The FDA lists Diclofenac Topical (arthritis pain) products; the earliest marketing or approval year on record is 1988.

12
Brand names ⓘ
1988
Earliest FDA record ⓘ

How Widely Diclofenac Topical (arthritis pain) Is Used (Medicaid Data)

How many Diclofenac Topical (arthritis pain) prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

4,673,607
Medicaid prescriptions filled (Q1–Q4 2025)
$142.3M paid by Medicaid, before rebates

How commonly is Diclofenac Topical (arthritis pain) prescribed? Of the 1,682 medications we measure, Diclofenac Topical (arthritis pain) ranks #44 by Medicaid prescriptions — more than 97% of them.

Where Diclofenac Topical (arthritis pain) ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Diclofenac Topical (arthritis pain) product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 0.01 mg/mg topical gel is the most-dispensed Diclofenac Topical (arthritis pain) product — about 72% of these Medicaid prescriptions.

diclofenac sodium 0.01 MG/MG Topical Gel Most dispensed

3,387,260 Medicaid prescriptions (Q1–Q4 2025) 72% of Diclofenac Topical (arthritis pain) prescriptions shown $66.6M paid by Medicaid, before rebates ≈ $20 per prescription, before rebates

23 of 255 listed NDCs had Medicaid claims. RxNorm 855633

diclofenac sodium 75 MG Delayed Release Oral Tablet

733,469 Medicaid prescriptions (Q1–Q4 2025) 16% of Diclofenac Topical (arthritis pain) prescriptions shown $8.8M paid by Medicaid, before rebates ≈ $12 per prescription, before rebates

27 of 346 listed NDCs had Medicaid claims. RxNorm 855926

diclofenac sodium 50 MG Delayed Release Oral Tablet

232,998 Medicaid prescriptions (Q1–Q4 2025) 5% of Diclofenac Topical (arthritis pain) prescriptions shown $2.8M paid by Medicaid, before rebates ≈ $12 per prescription, before rebates

19 of 217 listed NDCs had Medicaid claims. RxNorm 855906

diclofenac sodium 20 MG/ML Topical Solution

61,370 Medicaid prescriptions (Q1–Q4 2025) 1% of Diclofenac Topical (arthritis pain) prescriptions shown $10.4M paid by Medicaid, before rebates ≈ $169 per prescription, before rebates

8 of 39 listed NDCs had Medicaid claims. RxNorm 1487074

diclofenac potassium 50 MG Oral Tablet

61,179 Medicaid prescriptions (Q1–Q4 2025) 1% of Diclofenac Topical (arthritis pain) prescriptions shown $907,855 paid by Medicaid, before rebates ≈ $15 per prescription, before rebates

9 of 138 listed NDCs had Medicaid claims. RxNorm 855942

diclofenac sodium 0.03 MG/MG Topical Gel

56,803 Medicaid prescriptions (Q1–Q4 2025) 1% of Diclofenac Topical (arthritis pain) prescriptions shown $2.8M paid by Medicaid, before rebates ≈ $50 per prescription, before rebates

5 of 51 listed NDCs had Medicaid claims. RxNorm 855642

diclofenac potassium 25 MG Oral Tablet

56,007 Medicaid prescriptions (Q1–Q4 2025) 1% of Diclofenac Topical (arthritis pain) prescriptions shown $41M paid by Medicaid, before rebates ≈ $732 per prescription, before rebates

9 of 24 listed NDCs had Medicaid claims. RxNorm 857702

24 HR diclofenac sodium 100 MG Extended Release Oral Tablet

23,967 Medicaid prescriptions (Q1–Q4 2025) <1% of Diclofenac Topical (arthritis pain) prescriptions shown $868,745 paid by Medicaid, before rebates ≈ $36 per prescription, before rebates

4 of 119 listed NDCs had Medicaid claims. RxNorm 855657

Twice-Daily diclofenac epolamine 0.013 MG/MG Medicated Patch

21,190 Medicaid prescriptions (Q1–Q4 2025) <1% of Diclofenac Topical (arthritis pain) prescriptions shown $6.3M paid by Medicaid, before rebates ≈ $299 per prescription, before rebates

1 of 27 listed NDCs had Medicaid claims. RxNorm 855626

diclofenac sodium 1 MG/ML Ophthalmic Solution

16,149 Medicaid prescriptions (Q1–Q4 2025) <1% of Diclofenac Topical (arthritis pain) prescriptions shown $267,199 paid by Medicaid, before rebates ≈ $17 per prescription, before rebates

4 of 13 listed NDCs had Medicaid claims. RxNorm 854801

diclofenac sodium 25 MG Delayed Release Oral Tablet

14,888 Medicaid prescriptions (Q1–Q4 2025) <1% of Diclofenac Topical (arthritis pain) prescriptions shown $739,658 paid by Medicaid, before rebates ≈ $50 per prescription, before rebates

4 of 28 listed NDCs had Medicaid claims. RxNorm 855664

diclofenac sodium 15 MG/ML Topical Solution

6,165 Medicaid prescriptions (Q1–Q4 2025) <1% of Diclofenac Topical (arthritis pain) prescriptions shown $194,157 paid by Medicaid, before rebates ≈ $31 per prescription, before rebates

2 of 81 listed NDCs had Medicaid claims. RxNorm 857700

diclofenac 25 MG Oral Capsule

1,081 Medicaid prescriptions (Q1–Q4 2025) <1% of Diclofenac Topical (arthritis pain) prescriptions shown $335,097 paid by Medicaid, before rebates ≈ $310 per prescription, before rebates

4 of 17 listed NDCs had Medicaid claims. RxNorm 858342

diclofenac potassium 50 MG Powder for Oral Solution

1,081 Medicaid prescriptions (Q1–Q4 2025) <1% of Diclofenac Topical (arthritis pain) prescriptions shown $263,456 paid by Medicaid, before rebates ≈ $244 per prescription, before rebates

5 of 19 listed NDCs had Medicaid claims. RxNorm 859063

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 124 of the 1,374 listed Diclofenac Topical (arthritis pain) NDCs had Medicaid claims.

Diclofenac Topical (arthritis pain) Side Effects Reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Diclofenac Topical (arthritis pain) — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Diclofenac Topical (arthritis pain) are pain, fatigue, arthralgia; about 60% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

166,957
Reports mentioning it
60%
Reported as serious
12
Distinct effects shown
Most reported effects
Pain
16,576
Fatigue
14,579
Arthralgia
11,905
Rash
11,472
Rheumatoid Arthritis
11,195
Nausea
10,356
Abdominal Discomfort
10,100
Joint Swelling
9,460
Headache
9,420
Alopecia
9,082
Age groups
Adult · 11,622Elderly · 5,854Neonate · 355Adolescent · 160Child · 58Infant · 34

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Diclofenac Topical (arthritis pain) in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Diclofenac Topical (arthritis pain) FDA Approval History

How Diclofenac Topical (arthritis pain) went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Diclofenac Topical (arthritis pain) was first approved by the FDA in 1988 (Brand: VOLTAREN · Novartis); the first generic version was approved in 1995. It remains available in U.S. pharmacies today.

1988
Brand approved
Brand: VOLTAREN · Novartis
1995
First generic approved
Lower-cost ANDA competition begins
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Diclofenac Topical (arthritis pain) Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list 3 Diclofenac recalls since July 2021. All of them are still ongoing or began in the last six months. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Ongoing Class II Jan 27, 2026 · SUN PHARMACEUTICAL INDUSTRIES INC
Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
  • Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51… Lots: Lot # AD92721, Exp Date: 3/31/2027. FDA record D-0342-2026 →
Ongoing Class III Dec 22, 2025 · Cipla USA, Inc.
Failed PH Specifications
  • Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39 Lots: Batch XHBG; Exp. 08/31/2027 FDA record D-0291-2026 →
Ongoing Class II Jun 22, 2023 · ALEMBIC PHARMACEUTICALS, INC.
Defective Delivery System
  • Diclofenac Sodium Topical Solution USP, 2% w/w, 3.8 FL.OZ.(112 grams) bottles, Rx only, Manufactured for: Alembic Pharmaceuticals, Inc. Bedminster, NJ 07921, USA Manufactured by: Alembic Pharmaceutic… Lots: Lot #: 220151, 220152, 220153, Exp. Date 11/2024 FDA record D-0941-2023 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Diclofenac Topical (arthritis pain) in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
15
Strengths
31
Forms in current FDA listings
0 of 15
In current FDA listings No current FDA listing
Ingredient (IN) Diclofenac Topical (arthritis pain) RxCUI 3355
  1. Dose form (SCDF) Delayed Release Oral Capsule RxCUI 438955
    No current FDA listing
    Its 2 strengths (SCD)
    • 25 mg sodium RxCUI 1234844
    • 50 mg sodium RxCUI 1234853
  2. Dose form (SCDF) Delayed Release Oral Tablet RxCUI 371794
    No current FDA listing
    Its 3 strengths (SCD)
    • 25 mg sodium RxCUI 855664
    • 50 mg sodium RxCUI 855906
    • 75 mg sodium RxCUI 855926
  3. Dose form (SCDF) Extended Release Oral Capsule RxCUI 371793
    No current FDA listing
    Its 2 strengths (SCD)
    • 75 mg 24-hour, diclofenac sodium RxCUI 411848
    • 100 mg 24-hour, diclofenac sodium RxCUI 411846
  4. Dose form (SCDF) Extended Release Oral Tablet RxCUI 371799
    No current FDA listing
    Its 2 strengths (SCD)
    • 100 mg 24-hour, diclofenac sodium RxCUI 855657
    • 75 mg sodium RxCUI 857713
  5. Dose form (SCDF) Injectable Solution RxCUI 371795
    No current FDA listing
    Its strength (SCD)
    • 25 mg/mL sodium RxCUI 857705
  6. Dose form (SCDF) Medicated Patch RxCUI 1792846
    No current FDA listing
    Its 3 strengths (SCD)
  7. Dose form (SCDF) Ophthalmic Solution RxCUI 378986
    No current FDA listing
    Its strength (SCD)
  8. Dose form (SCDF) Oral Capsule RxCUI 376352
    No current FDA listing
    Its 3 strengths (SCD)
    • 18 mg RxCUI 1442116
    • 25 mg RxCUI 858342
    • 35 mg RxCUI 1442128
  9. Dose form (SCDF) Oral Solution RxCUI 393225
    No current FDA listing
    Its strength (SCD)
    • 0.25 mg/mL sodium RxCUI 857689
  10. Dose form (SCDF) Oral Tablet RxCUI 371798
    No current FDA listing
    Its 3 strengths (SCD)
    • 25 mg potassium RxCUI 857702
    • 50 mg potassium RxCUI 855942
    • 75 mg potassium RxCUI 2753518
  11. Dose form (SCDF) Powder for Oral Solution RxCUI 1856554
    No current FDA listing
    Its strength (SCD)
    • 50 mg potassium RxCUI 859063
  12. Dose form (SCDF) Rectal Suppository RxCUI 371796
    No current FDA listing
    Its 4 strengths (SCD)
    • 12.5 mg sodium RxCUI 857698
    • 25 mg sodium RxCUI 857703
    • 50 mg sodium RxCUI 857709
    • 100 mg sodium RxCUI 857696
  13. Dose form (SCDF) Topical Cream RxCUI 438948
    No current FDA listing
    Its strength (SCD)
    • 10 mg/mL sodium RxCUI 1043479
  14. Dose form (SCDF) Topical Gel RxCUI 377959
    No current FDA listing
    Its 2 strengths (SCD)
  15. Dose form (SCDF) Topical Solution RxCUI 393139
    No current FDA listing
    Its 2 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

Diclofenac Topical (arthritis pain) Supply and Shortage Status

Whether Diclofenac Topical (arthritis pain) is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.

Diclofenac Topical (arthritis pain) is not in shortage right now; the FDA has 6 past shortage records for it.

✅No current shortage of Diclofenac Topical (arthritis pain) on record
To be discontinued Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-11)
Teva Pharmaceuticals USA, Inc. · Since 08/13/2026 · Updated 08/13/2026
To be discontinued Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-96)
Teva Pharmaceuticals USA, Inc. · Since 08/13/2026 · Updated 08/13/2026
To be discontinued Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-96)
Teva Pharmaceuticals USA, Inc. · Since 08/13/2026 · Updated 08/13/2026
To be discontinued Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-11)
Teva Pharmaceuticals USA, Inc. · Since 08/13/2026 · Updated 08/13/2026
To be discontinued Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-06)
Teva Pharmaceuticals USA, Inc. · Since 08/13/2026 · Updated 08/13/2026
To be discontinued Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-06)
Teva Pharmaceuticals USA, Inc. · Since 08/13/2026 · Updated 08/13/2026

Source: openFDA, from the FDA Drug Shortages database.

Diclofenac Topical (arthritis pain) Brand Names

Diclofenac Topical (arthritis pain) has 12 brand names on record: Pennsaid, Voltaren Arthritis Pain, Zorvolex, Licart and others. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Pennsaid 2009, discontinued Voltaren Arthritis Pain 2007 Zorvolex 2013, discontinued Licart 2018 Aleve Arthritis Pain Lofena Xiclo Flector 2007 Voltaren the first brand, 1988 Cataflam 1993 Zipsor 2009 Cambia 2009

Sources for This Diclofenac Topical (arthritis pain) Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Nov 1, 2019, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Diclofenac Topical (arthritis pain).
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
1
Linked representative label ⓘ
Proficient Rx LP
Linked label effective
Nov 1, 2019
Composite sections available
24
Linked SPL Set ID
a7447467-79e0-436e-a273-d1ddd06169cf
Linked SPL Document ID
b7cca998-edc7-40b5-bc62-b789921ad6c8
Open the linked representative label on DailyMed ↗
NDC package records associated with this linked SPL 1

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Proficient Rx LP is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →